Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Plos One|November 28, 2012
In vivo imaging of hierarchical spatiotemporal activation of caspase-8 during apoptosisKatsuya Kominami, Takeharu Nagai, Tatsuya Sawasaki, et al.
Translational Lung Cancer Research|January 9, 2026
Additional 1.1-mm cryobiopsy trial guided by rapid on-site cytologic evaluation of touch imprint cytology result of small forceps biopsy in peripheral pulmonary lesions: a prospective single-center studyYuki Takigawa, Ken Sato, Suzuka Matsuoka, et al.
Molecular Cancer Therapeutics|May 29, 2025
Colony-Stimulating Factor-1 Receptor Inhibitor Augments Osimertinib-Induced Antitumor Immunity via Suppression of Macrophages in Lung Cancer Harboring EGFR MutationSachi Okawa, Shuta Tomida, Tadahiro Kuribayashi, et al.
Respirology Case Reports|June 8, 2026
Marked Respiratory Improvement After ECMO-Supported Exchange From Metallic to Silicone Stent in Tracheobronchial Stenosis due to Tuberculosis: A Case ReportMayu Goda, Yuki Takigawa, Ken Sato, et al.
Cancer Science|February 27, 2026
TGF-β Inhibitor Potentiates Osimertinib-Induced Anti-Tumor Immunity in Egfr-Mutant Lung CancerTadahiro Kuribayashi, Jun Nishimura, Sachi Okawa, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Limited Immune-Mediated Efficacy of Anti-PD-L1/VEGF in EGFR-TKI-Naïve Egfr-Mutant Lung Cancer with Non-Inflamed Tumor MicroenvironmentAtsuko Hirabae, Tadahiro Kuribayashi, Shuta Tomida, et al.
Molecular Oncology|May 22, 2026
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancerJun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, et al.
Cancer Immunology Research|July 8, 2022
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung CancerKazuya Nishii, Kadoaki Ohashi, Shuta Tomida, et al.
Respiratory Investigation|March 15, 2026
Bridging therapy with airway stent placement followed by immune checkpoint inhibitors in patients with lung cancer and malignant airway disorders: A retrospective studyYuki Takigawa, Ken Sato, Kenichiro Kudo, et al.
Cancer Science|June 2, 2026
Afatinib Overcomes Osimertinib Resistance via Egfr V804F Mutation in a Syngeneic Egfr-Mutant Lung Cancer Mouse ModelTakaaki Tanaka, Masato Fujitani, Masataka Taoka, et al.
Pageof 6